CANCER-ASSOCIATED IMMUNOSUPPRESSION INHIBITOR

The present invention relates to a glyco-engineered Fc fragment-bearing compound for its use as an immunosuppression inhibitor in the treatment of a cancer-associated immunosuppression. The invention further relates to a pharmaceutical composition comprising at least this glyco-engineered Fc fragmen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DONNADIEU Emmanuel, LAHMAR Mehdi, DEGOVE Stéphane, BOUGHERARA Houcine, PROST Jean-françois, BARRET Jean-marc
Format: Patent
Sprache:eng ; spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!